Skip to main content

Advertisement

Log in

Reply

  • Letter to the editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Eur J Nucl Med 2001; 28:214–220.

    Article  CAS  PubMed  Google Scholar 

  2. Mariani G, Molea N, La Civita L, Porciello G, Lazzeri E, Ferri C. Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucherés disease. Eur J Nucl Med 1996; 23:466–470.

    Article  CAS  PubMed  Google Scholar 

  3. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman L, Davidson A, Jones AG. Uptake of the cation hexaxis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50:2198–2202.

    CAS  PubMed  Google Scholar 

  4. Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma. Blood 1998; 92:2844–2855.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Fonti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fonti, R., Del Vecchio, S. & Pace, L. Reply. Eur J Nucl Med 28, 1431–1432 (2001). https://doi.org/10.1007/s002590100577

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590100577

Navigation